Prostate-specific antigen after neoadjuvant androgen suppression in prostate cancer patients receiving short-term androgen suppression and external beam radiotherapy: pooled analysis of four NRG Oncology RTOG randomized clinical trials

PURPOSE: To validate if prostate specific antigen (PSA) level after neoadjuvant androgen suppression (neoAS) is associated with long-term outcome after neoAS and external radiation therapy (RT) with concurrent short-term AS in prostate cancer patients. METHODS: 2404 patients treated with neoAS prior...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Int J Radiat Oncol Biol Phys
Main Authors: Hallemeier, Christopher L, Zhang, Peixin, Pisansky, Thomas M, Hanks, Gerald E, McGowan, David G, Roach, Mack, Zeitzer, Kenneth L, Firat, Selim Y, Husain, Siraj M, D’Souza, David P, Souhami, Luis, Parliament, Matthew B., Rosenthal, Seth A, Lukka, Himanshu R, Rotman, Marvin, Horwitz, Eric M, Miles, Edward F, Paulus, Rebecca, Sandler, Howard M
Formato: Artigo
Idioma:Inglês
Publicado em: 2019
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6646073/
https://ncbi.nlm.nih.gov/pubmed/30959123
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ijrobp.2019.03.049
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados